#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Greece +4

  • A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Spain

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Hungary

  • A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

    Recruiting

    3 1
    Investigated Drugs:
    Austria Germany Greece Italy

  • Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

    Recruiting

    3 1
    Investigated Drugs:
    Portugal Spain

  • Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal Spain

  • A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Denmark France Germany Greece +9

  • A study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark Germany Sweden

  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Recruiting

    2 1 1
    Italy The Netherlands Spain

  • Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors

    Recruiting

    2 1 1
    The Netherlands Spain